North China Pharmaceutical Company Ltd. (600812.SS)

CNY 5.49

(-0.54%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 20.95 Billion 21.22 Billion 24.92 Billion 23.93 Billion 18.54 Billion 17.91 Billion
Total Current Assets 8.01 Billion 8.98 Billion 12.71 Billion 12.11 Billion 7.78 Billion 7.35 Billion
Cash And Short Term Investments 988.27 Million 1.68 Billion 5.3 Billion 4.9 Billion 1.22 Billion 1.24 Billion
Cash and Cash Equivalents 988.27 Million 1.68 Billion 5.3 Billion 4.9 Billion 1.22 Billion 1.24 Billion
Short Term Investments - - -85.93 Million -106.17 Million -121.73 Million -115.46 Million
Net Receivables 4.01 Billion 4.6 Billion 4.8 Billion 4.5 Billion 4.26 Billion 3.87 Billion
Inventory 2.6 Billion 2.52 Billion 2.39 Billion 2.45 Billion 2.1 Billion 2.07 Billion
Other Current Assets 401.51 Million 172.83 Million 213.76 Million 249.92 Million 188.96 Million 164.12 Million
Total Non-Current Assets 12.93 Billion 12.23 Billion 12.21 Billion 11.82 Billion 10.75 Billion 10.55 Billion
Net PPE 7.47 Billion 7.92 Billion 8.3 Billion 8.5 Billion 8.35 Billion 8.49 Billion
Good Will And Intangible Assets 4.08 Billion 3.28 Billion 2.95 Billion 2.62 Billion 1.58 Billion 1.29 Billion
Good Will 3.33 Million 3.33 Million 3.33 Million 3.33 Million 3.33 Million 3.33 Million
Intangible Assets 4.07 Billion 3.27 Billion 2.95 Billion 2.62 Billion 1.58 Billion 1.28 Billion
Long-Term Investments 1.21 Billion 917.98 Million 961.83 Million 705.59 Million 827.45 Million 792.72 Million
Tax Assets 52.1 Million 50.26 Million 45.02 Million 43.55 Million 40.77 Million 39.54 Million
Other Non Current Assets 112.6 Million 59.44 Million -58.83 Million -59.32 Million -59.32 Million -59.04 Million
Other Assets 0.00 1.00 - - - 1.00
Total Liabilities 14.68 Billion 14.99 Billion 17.91 Billion 16.87 Billion 12.91 Billion 12.4 Billion
Total Current Liabilities 10.26 Billion 12.4 Billion 14.23 Billion 11.75 Billion 10.08 Billion 10.7 Billion
Account Payables 1.9 Billion 2.78 Billion 2.89 Billion 2.6 Billion 2.59 Billion 2.5 Billion
Tax Payables 34.57 Million 119.7 Million 115.15 Million 116.07 Million 126.4 Million 123.11 Million
Short Term Debt 7.34 Billion 8.5 Billion 10.14 Billion 8.17 Billion 6.57 Billion 6.4 Billion
Deferred Revenue 313.25 Million 295.86 Million 1.19 Billion 961.95 Million 704.1 Million 123.11 Million
Other Current Liabilities 697.84 Million 824.64 Million 6.51 Million 11.87 Million 205.68 Million 1.66 Billion
Total Non Current Liabilities 4.41 Billion 2.58 Billion 3.67 Billion 5.12 Billion 2.83 Billion 1.69 Billion
Long-Term Debt 4.08 Billion 2.54 Billion 3.62 Billion 4.61 Billion 2.14 Billion 1.28 Billion
Deferred Revenue Non Current 36.8 Million 40.06 Million 44.43 Million 48.57 Million 52.53 Million 36 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 299.16 Million 900 Thousand 899.99 Thousand 456.41 Million 2.94 Million 1.28 Billion
Other Liabilities 0.00 - 1.00 1.00 - -
Total Equity 6.27 Billion 6.22 Billion 7.01 Billion 7.05 Billion 5.62 Billion 5.51 Billion
Stock Holders Equity 5.31 Billion 5.3 Billion 6.08 Billion 6.12 Billion 5.56 Billion 5.44 Billion
Common Stock 1.71 Billion 1.71 Billion 1.71 Billion 1.63 Billion 1.63 Billion 1.63 Billion
Retained Earnings -629.04 Million -606.5 Million 188.48 Million 232.39 Million 186.75 Million 86.52 Million
Accumulated other comprehensive income 349.24 Million 311.52 Million 302.14 Million 362.99 Million 412.95 Million 281.22 Million
Common Stock Equity 5.31 Billion 5.3 Billion 6.08 Billion 6.12 Billion 5.56 Billion 5.44 Billion
Capital Lease Obligation 299.16 Million 413.39 Million 326.73 Million 280.69 Million 635.6 Million 367.15 Million
Total Investments 1.21 Billion 917.98 Million 875.9 Million 599.42 Million 705.72 Million 677.26 Million
Total Debt 11.72 Billion 11.04 Billion 13.77 Billion 12.79 Billion 8.71 Billion 7.69 Billion
Net Debt 10.74 Billion 9.36 Billion 8.47 Billion 7.88 Billion 7.49 Billion 6.44 Billion

Balance Sheet Charts